Table 5. ROSSINI trial economic evaluation: summary of incremental costs and incremental QALYs across the analysed scenarios.
Scenario | Variable | Mean difference(WEPD – standard care) | 95% BCa CI | ICER |
Base-case unadjusted | Total cost (£) | 290 | −372 to 949 | WEPD is dominated |
QALY | −0.00002 | −0.0018 to 0.0017 | ||
Base-case adjusted | Total cost (£) | 311 | −273 to 1012 | 1,712 k/QALY |
QALY | 0.0002 | −0.0015 to 0.0019 | ||
Complete case unadjusted | Total cost (£) | 237 | −407 to 892 | 740 k/QALY |
QALY | 0.0003 | −0.0023 to 0.0016 | ||
Complete case adjusted | Total cost (£) | 369 | −214 to 976 | WEPD is dominated |
QALY | −0.0001 | −0.0022 to 0.0019 |